NEW YORK (GenomeWeb News) – Epigenomics today said that it raised almost €5 million ($6.7 million) in a successful completion of a capital increase.

The increase was achieved through a rights issue and a subsequent private placement. As a result of the capital increase, Epigenomics said its cash runway has been extended to at least the fourth quarter of 2013.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A trio of researchers is trying to raise money to sequence and analyze the genome of a cat with a suite of unusual traits.

Two Johns Hopkins researchers discuss the need for evidence-based data analysis.

In PLOS this week: genes under positive selection in Plasmodium falciparum populations, genetic variation in Epstein-Barr viruses, and more.

Cancer clinical trial patients settle with Anil Potti and Duke University.